Longer-term fourth ventricular 5-thioglucose infusion increases body fat in the rat.
5-Thioglucose (5-TG) has been shown to increase food intake after acute administration. To determine the longer-term effects of 5-TG on feeding and body composition, thirty-four female Sprague-Dawley rats were cannulated into the fourth ventricle and infused with artificial CSF and either 0.01 M 5-TG or 0.1 M 5-TG using osmotic pumps. Food intake and body weight were monitored daily. Rats were killed after 14 days of infusion. Carcass and fatpad weights were measured, and body compositions were determined. Food intake was not different during the first week of infusion; however, cumulative food intake was decreased in the 0.1 M 5-TG group during the second week as compared to the CSF control group. Body weight and carcass weight of this group also decreased as compared to the control. The group receiving the higher dose of 5-TG (0.1 M) had increased fatpad weights in all three depots examined (inguinal, retroperitoneal, and perimetrial depot); the group with lower dose of 5-TG infusion (0.01 M) increased the fatpad weights in the retroperitoneal and perimetrial depot, as compared to the CSF group. Data from the body composition analysis were consistent with the results of the fatpad weights. In conclusion, the present study demonstrated that chronic fourth ventricular 5-TG infusion increased body fat without increasing food intake, suggesting that energy expenditure is decreased under this condition. The results of this study indicate that glucose metabolism in the hindbrain is important in the control of energy expenditure, body fat deposition, and thus energy balance regulation.
He
B
B
Department of Foods and Nutrition, University of Georgia, Athens 30602, USA.
White
B D
BD
Edwards
G L
GL
Martin
R J
RJ
D000273:Adipose Tissue / Q000033:anatomy & histology*; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects; D005247:Feeding Behavior / Q000187:drug effects*; D005260:Female; D005947:Glucose / Q000008:administration & dosage / Q000031:analogs & derivatives*; D007276:Injections, Intraventricular; D051381:Rats; D017207:Rats, Sprague-Dawley; D012249:Rhombencephalon / Q000502:physiology; D013997:Time Factors
C003002:5-thio-D-glucose; D005947:Glucose